Company Profile
BioLife Solutions Stock Price, News & Catalysts
- Ticker:
- BLFS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
36.78 USD (-5.33%)
Close
Last updated: October 1, 2026
1.34B USD
Market cap
Why the stock is moving
As of Oct 1, 2026, BLFS closed down 5.33% at $36.78. No new same-company headline was identified in the current news window.
Company overview
Cell and Gene Therapy Tools Supplier
BioLife Solutions develops and supplies cell-processing tools used by biotechnology companies, clinical programs, and commercial manufacturers across the cell and gene therapy market.
Biopreservation Media
CryoStor and HypoThermosol media are designed to preserve cells and tissues during freezing, storage, shipping, and clinical handling. These products are incorporated into a large number of clinical trials and approved cell and gene therapies.
Cell-Processing Consumables
The portfolio includes CellSeal cryogenic vials, human platelet lysate products, and other materials used in cell manufacturing. These products support closed or controlled workflows as therapies move from research into regulated production.
Embedded Clinical-to-Commercial Model
Once a BioLife product is written into a therapy's manufacturing process, changing suppliers can require technical and regulatory work. This creates recurring demand as customer programs advance from clinical trials to commercial treatment volumes.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of BioLife Solutions (BLFS)?
BioLife Solutions (BLFS) most recently closed at 36.78 USD, a -5.33% move versus the previous session.
What is the market cap of BioLife Solutions (BLFS)?
BioLife Solutions currently has a market capitalization of 1.34B USD on BioPharmSignal.
What does BioLife Solutions do?
Cell and Gene Therapy Tools Supplier BioLife Solutions develops and supplies cell-processing tools used by biotechnology companies, clinical programs, and commercial manufacturers across the cell and gene therapy market. Biopreservation Media CryoStor and HypoThermosol media are designed to preserve cells and tissues during freezing, storage, shipping, and...
On which exchange is BLFS stock listed?
BioLife Solutions (BLFS) is associated with NASDAQ, United States, Biopharma.
What is Cell?
Cell and Gene Therapy Tools Supplier BioLife Solutions develops and supplies cell-processing tools used by biotechnology companies, clinical programs, and commercial manufacturers across the cell and gene therapy market.
Which conditions is BioLife Solutions targeting with Cell?
Cell and Gene Therapy Tools Supplier BioLife Solutions develops and supplies cell-processing tools used by biotechnology companies, clinical programs, and commercial manufacturers across the cell and gene therapy market. Biopreservation Media CryoStor and HypoThermosol media are designed to preserve cells and tissues during freezing, storage, shipping, and...
What is Gene?
Cell and Gene Therapy Tools Supplier BioLife Solutions develops and supplies cell-processing tools used by biotechnology companies, clinical programs, and commercial manufacturers across the cell and gene therapy market.
What is Therapy?
Cell and Gene Therapy Tools Supplier BioLife Solutions develops and supplies cell-processing tools used by biotechnology companies, clinical programs, and commercial manufacturers across the cell and gene therapy market.